IN THE last 6 years, ever since Hench and his associates' first pointed out the apparent usefulness of corticotrophin (ACTH) and cortisone in the treatment of rheumatic fever and rheumatic carditis, various investigators, both from this country and abroad, have expressed divergent opinions on the efficacy of these hormones in the treatment of rheumatic fever. The opinions range from those of the ultraoptimistic group, who believe hormones terminate the disease, to those of the over pessimistic group, who are convinced that hormones are in no way a better suppressive drug than aspirin.2 The report of a cooperative clinical trial,3 which has recently been published simultaneously in this country and in the United Kingdom, indicated that there was no consistent pattern in the response of the various manifestations of rheumatic fever in patients treated for 6 weeks with ACTH, cortisone, or aspirin, and that "no consistent difference in the behavior of murmurs present at the start of treatment was noted except that the soft apical systolic murmurs disappeared more rapidly in hormone treated groups. " This clinical trial, usually referred to as the Cooperative Study, was a study in which 6 centers in the United Kingdom, 1 in Canada, and 5, including the House of the Good Samaritan, in the United States participated.
The divergencies of opinion regarding the relative efficacy of hormoines in the treatment of rheumatic fever and rheumatic carditis led us to consider whether these differences could be explained, in part, on the basis of differences in dosage, in duration of therapy, and in duration of illness before starting therapy. The purpose of the study being reported here was to explore these possibilities. Heart(damage being the most important effect of rheumatic fever, the results of hormone therapy ill this study have been evaluated regarding data pertaining to carditis only. Furthermore, since carditis is best indicated by the presence of significant murmurs, this study has heen confined to observations of the frequency with which murmurs present at the start of the treatment disappeared completely at the end of the twentieth week from the beginning of therapy. It should be noted that the present study is not concerned with the relative merits of hormones and salicylates in the treatment of rheumatic fever nor with the toxic and other undesirable effects of these drugs.
ROY AND MASSELL matic fever prior to therapy, were selected for this study. Carditis was not considered to be present unless there were significant murmurs.
All of the patients with significant murmurs in this study had signs of mitral regurgitation or signs of aortic regurgitation. There were no instances of aortic stenosis or mitral stenosis. Mitral regurgitation was diagnosed on the basis of a long, blowing systolic murmur that was best heard at the apex, was of more than slight (grade II) intensity at the apex, radiated to the left axilla, and did not change appreciably with respiration or with change in the patient's position. In some instances, this significant systolic murmur was accompanied by a rumbling mid-diastolic murmur at the apex. Aortic regurgitation was diagnosed on the basis of an early diastolic blowing murmur which, even when faint, occupied more than half of diastole.
Of the 88 patients with significant murmurs prior to therapy, 41 were treated with relatively small doses of the hormones for an average of 6 weeks and 47 were treated with relatively large doses of the hormones for an average of 14 weeks. Those in the small-dose group were given intramuscularly a total of 1100 to 2400 units of lyophilized ACTH* or 4.1 Gm. of cortisone.t Those in the large-dose group were given a total of 4100 to 7000 units of ACTH-gel * All the ACTH used in this study was donated by the Armour Laboratories. The kind that was used in the small-dose group was a water-soluble lyophilized preparation standardized in terms of USP units. The USP unit is expressed as a milligram equivalent of ACTH lot number LA-IA. That used in the large-dose group was a purified longacting preparation in a gelatin base supplied as H. P. Acthar gel and standardized in terms of Armour units. intramuscularly or 13.0 to 15.5 Gm. of cortisone orally.
All of the patients in the small-dose group were treated prior to July 1952; all of the patients in the large-dose group were treated after that date.
The frequency of important clinical and laboratory signs of rheumatic fever and carditis in the 41 cases of the small-dose group is compared in table 1 with the frequency in the 47 cases of the large-dose group. Such manifestations as cardiac enlargement, joint symptoms, elevation of the sedimentation rate, elevation of the antistreptolysin-O titer, and prolongation of the P-R interval occurred with almost exactly the same frequency in the 2 groups. The incidence of pericarditis and congestive failure was slightly greater in the small-dose group, but the incidence of subcutaneous nodules and chorea was somewhat greater in the large-dose group.
RESULTS AND DISCUSSION
The 41 patients in the small-dose group and the 47 patients in the large-dose group were divided into subgroups according to the interval that elapsed between the onset of the rheumatic fever attack and the beginning of hormone therapy. The frequency with which all significant murmurs had completely disappeared by the twentieth week from the beginning of therapy for each sub-group is shown in table 2.
From the data in the table it is evident that, in both the small and the large-dose groups, the shorter the duration of illness prior to the start of therapy, the greater the frequency of complete disappearance of all significant murmurs. Thus, in the small-dose group the frequency of disappearance of murmurs decreased from 50 per cent for patients ill 1 to 7 days to 0 per cent for patients ill more than 42 days, and in the 4EFFECT OF HORMONES ON ACUTE RHEUMATIC CARDITIS large-dose group the frequency for the corresponding subgroups decreased from 73 per cent to 14 per cent.
It is also to be noted that in each duration subgroup, the frequency of complete disappearance of all significant murmurs in the largedose group was consistently greater than the frequency in the small-dose group. Thus, for the 4 successive duration subgroups the percentages of disappearance of significant mirmurs in the large-dose and the small-dos groups were respectively 73 and 50; 43 and 25; 40 and 13; and 14 and nil. For all patients, irrespective of duration of illness, the frequency of disappearance of significant murmurs was 40 per cent for the large-dose group and only 20 per (cent for the small-dose group, a ratio of 2 to 1.
Statistical analysis reveals the following: in the large-dose group the difference in frequency of disappearance of murmurs in patients treated within 7 days of onset of rheumatic fev-er and in patients treated after an elapse of more than 42 days is significant, in that p is almost .01; the frequency of disappearance of murmurs in all of the patients in the large-dose group treated within 42 In regard to the apparent relation of frequency of disappearance of murmurs to duration of illness, consideration must be given to the possibility that, through natural selection, variation in severity of disease entered into the picture and influenced results. As previously pointed out,2 patients with mild rheumatic fever may not have continued to have active disease long enough to be included in the groups of long duration, which, in contrast to those of short duration, may therefore have Leen weighted with more severe cases of rheumatic fever. On this basis alone, the cases of long duration might be expected to show a higher frequency of persistent murmurs.
On the other hand, all of the patients in this study presented signs of definite heart disease at the time therapy was started; therefore they cannot be considered to be cases of mild rheumatic fever. Furthermore, the difference in frequencies of disappearance of murmurs among those ill for a relatively short period and among those ill for a long period is so striking that it is difficult to accept natural selection as the only explanation. Finally, natural selection alone would not account for the differences in the frequency of disappearance of murmurs for those patients treated with large doses of hormones and those treated with small doses.
From the foregoing discussion, it is evident that final conclusions are not yet justified. Nevertheless, the data presented here suggest that results of hormone therapy in rheumatic fever are related to the time allowed to elapse before treatment is started, to the dosage of the hormone, and to the duration of therapy. The data also emphasize the importance of taking into consideration duration of illness, dosage of drugs used, and duration of treatment in any study aimed at comparing therapeutic agents in rheumatic fever.
SUMMARY
Of 160 rheumatic fever patients under the age of 17 years who were treated with variable doses of ACTH or cortisone for varying lengths of time, 88 patients were in their initial attack of rheumatic fever and had definite signs of carditis.
The frequency of complete disappearance of significant murmurs in 41 patients treated with relatively small doses of hormones was compared with that in 47 patients treated with relatively large doses of hormones. Results were related to the duration of illness prior to beginning of therapy. In 1)oth the small-dose and the large-dose groups, the shorter the duration of illness prior to start of therapy the greater the frequency of disappearance of all significant murmurs. It was also noted that the frequency of disappearance of significant murmurs in the large-dose group was consistently greater than that in the small-dose group.
Data presented here suggest that results of hormone therapy in rheumatic carditis are related to the time allowed to elapse before treatment is started, to the dosage of the hormones, and to the duration of therapy. 
